Fundraising FoxSage Therapeutics
Cambridge, US · Founded 2010 · Delaware corporation · 2 known investors
Find your way into Sage Therapeutics
Sign up to see every warm intro you have to Sage Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sage Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KI
Kimi IguchiChief Financial Officer2013–2024Kimi Iguchi is a financial executive with over 25 years of experience in biotechnology, having worked on capital raising, strategic partnerships, and financial operations across multiple companies from early-stage research through commercialization. He has served in board and audit committee roles focused on corporate governance and strategic oversight.
MC
Michael CloonanExecutive
AM
Anne Marie CookExecutive
SJ
Stephen J. KanesExecutive
JM
Jeffery M. JonasExecutive
EB
Elizabeth BarrettNamed on SEC filing
JF
James FratesNamed on SEC filing
GG
Geno GermanoNamed on SEC filing
GG
George GolumbeskiNamed on SEC filing
Investors · 2
ARCH Venture PartnersreportedChicago · $50K – $250M
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Third Rock VenturesreportedBoston · $100K – $5Mvia Kevin Starr · board
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$698M disclosed across 3 rounds · 2014–2020
▶$650MraisedJan 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$650MraisedJan 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Barry GreeneExecutive Officer, Director
- Kimi IguchiExecutive Officer
- Michael CloonanExecutive Officer
- Anne Marie CookExecutive Officer
- Stephen J. KanesExecutive Officer
- Albert RobichaudExecutive Officer
- Jeffrey M. JonasExecutive Officer, Director
- Elizabeth BarrettDirector
- James FratesDirector
- Geno GermanoDirector
- George GolumbeskiDirector
- Steven PaulDirector
- Kevin P. StarrDirector
- Michael F. ColaDirector
- Offering amount
- $650M
- Amount sold
- $650M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38MraisedMar 2014 · 15 investors · Other Health CareRule 506(b)
▶$38MraisedMar 2014 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven PaulDirector
- Robert T. NelsenDirector
- Kevin StarrDirector
- Jeffery M. JonasExecutive Officer, Director
- Kimi IguchiExecutive Officer
- Offering amount
- $38M
- Amount sold
- $38M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$10MraisedJan 2014 · 3 investors · Other Health CareRule 506(b)
▶$10MraisedJan 2014 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven PaulDirector
- Kimi IguchiExecutive Officer
- Jeffery M. JonasExecutive Officer, Director
- Robert T. NelsenDirector
- Kevin StarrDirector
- Offering amount
- $20M
- Amount sold
- $10M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
6 people who came through Sage Therapeutics went on to found or lead other companies.
Steve PaulDirectorFounded Voyager Therapeutics, Inc. +1Jamil BegSenior Director, Business Development & Brand LeaderFounded Nido Biosciences +1Carlos LoyaDrug Discovery and Porfolio StrategyFounded Aldebaran TherapeuticsKiran ReddyChief Business OfficerFounded PraxisDario DollerSenior Director, Head of Exploratory ResearchFounded Modulate BioSean RussellDirector, Regulatory OperationsFounded Model Medicines
Frequently asked questions
- Who are Sage Therapeutics's investors?
- Sage Therapeutics's investors include ARCH Venture Partners, Third Rock Ventures.
- How much funding has Sage Therapeutics raised?
- Sage Therapeutics has disclosed $698M raised across 3 rounds.
- Where is Sage Therapeutics headquartered?
- Sage Therapeutics is headquartered in Cambridge, US.